TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Draig Therapeutics Appoints Seasoned Neuroscience Leader Ivana Magovčević-Liebisch as President and Chief Executive Officer

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Draig Therapeutics
Draig Therapeutics Appoints Seasoned Neuroscience Leader Ivana Magovčević-Liebisch as President and Chief Executive Officer

Draig Therapeutics has appointed Dr. Ivana Magovčević-Liebisch as its new President and CEO, succeeding Dr. Ruth McKernan. Dr. Magovčević-Liebisch brings over 25 years of biopharmaceutical leadership experience, previously leading Vigil Neuroscience until its acquisition by Sanofi.

Insights
HOOD   neutral

Company was mentioned but no specific performance details were provided in the article


SNY   neutral

Acquired Vigil Neuroscience, indicating strategic interest in the neuroscience sector